Join to View Full Profile
3601 The Vanderbilt ClinicNashville, TN 37232
Phone+1 615-322-3000
Dr. Tosoian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Michigan Medical CenterTranslational Cancer Research, Urologic Oncology, 2018 - 2021
Johns Hopkins UniversityResidency, Urology, 2012 - 2018- Johns Hopkins University School of MedicineClass of 2012, MD, MPH
Certifications & Licensure
TN State Medical License 2021 - 2027
MI State Medical License 2018 - 2022
American Board of Urology Urology
American Board of UrologyUrology
Publications & Presentations
PubMed
- 1 citationsBlood- and urine-based biomarkers for the detection of clinically significant prostate cancer: a contemporary review.Keavash D Assani, Janene M Pierce, Lan Anh Galloway, Jeffrey J Tosoian
Current Opinion in Urology. 2025-09-01 - Time to Rethink Gleason Grading.Daniel D Joyce, Jeffrey J Tosoian
The Journal of Urology. 2025-06-01 - 3 citationsClinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non-Digital Rectal Examination Urine.Jeffrey J Tosoian, Yuping Zhang, Jacob I Meyers, Spencer Heaton, Javed Siddiqui
The Journal of Urology. 2025-05-01
Journal Articles
- Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy from a Statewide Improvement Collabora...Gregory B Auffenberg, Jeffrey Tosoian, Richard Sarle, William K Johnston, Eduardo Kleer, Khurshid R Ghani, James Montie, JAMA Surgery
- Association of Tumor-Infiltrating T-cell Density with Molecular Subtype, Racial Ancestry and Clinical Outcomes in Prostate CancerTamara L Lotan, Edward M Schaeffer, Jeffrey J Tosoian, Scott A Tomlins, Nature
Authored Content
- The Androgen Signaling Axis and Risk Stratification for High-Grade Prostate CancerMarch 2018
- Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving PracticeFebruary 2018
Press Mentions
Prostate Cancer: After Years of Decline, Cases Rose Steadily over Past DecadeSeptember 5th, 2025- The Importance of Prostate Cancer Screenings, How Pharmacies Are Balancing Care and Costs; Plus Other News Stories with VUMC SourcesMay 2nd, 2025
- Males Who Skip Prostate Screenings Could Face 45% Higher Risk of Death: StudyMarch 27th, 2025
Grant Support
- Michigan-VUMC Biomarker Characterization CenterUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
